கிர்த்திபைய் மேத்தா News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Indian PE firm ChrysCapital picks 27% stake in Corona Remedies Photographer: Krisztian Bocsi/Bloomberg April 5, 2021 Indian homegrown private equity (PE) major ChrysCapital has picked up a 27% stake in Gujarat-based drug manufacturer Corona Remedies through a secondary transaction, according to a press statement issued jointly by the companies on Monday. While other financial details of the transaction were not disclosed, DealStreetAsia had reported on March 30 that ChrysCapital is close to investing $100 million in Corona Remedies. The report also mentioned that Malaysian PE firm Creador is exiting as part of the transaction. Creador had acquired a 20% stake in Corona Remedies for Rs 120 crore in 2016.

Ankur mehtaKirtibhai mehtaNirav mehtaShardul amarchand mangaldasKshitij shethCorona remediesCapital advisorsVertices partnersஅன்குர் மேத்தாகிர்த்திபைய் மேத்தாநீரவ் மேத்தாஷார்துள் அமர்சந்த் மங்கல்தாஸ்க்ஷித்ிஜ் உறைகொரோனா வைத்தியம்செங்குத்துகள் கூட்டாளர்கள்